Thyroid cancer is the most common endocrine malignancy; it accounts for approximately 1%
of all new case of cancer each year, and its incidence has increased significantly over the …

Thyroid cancer is the most common endocrine malignancy, and its incidence is rising in the
USA and other countries. Papillary and follicular thyroid carcinomas are the two most …

Thyroid cancer derived from follicular cells (TCDFC) comprises well-differentiated (papillary
and follicular) carcinoma, poorly differentiated carcinoma, and anaplastic carcinoma …

This review describes the gene expression profile changes associated with the presence of
different mutations that contribute to thyroid cell carcinogenesis. The results are discussed in …

Well-differentiated thyroid carcinomas comprise two well-defined histological types: papillary
and follicular (PTCs and FTCs, respectively). Despite being derived from the same cell …

Thyroid cancer poses a significant clinical challenge, and our understanding of its
pathogenesis is incomplete. To gain insight into the pathogenesis of papillary thyroid …

Thyroid cancer is the most common malignant tumor of the endocrine system and accounts
for approximately 1% of all newly diagnosed cancer cases. The most frequent type of thyroid …

Thyroid carcinoma is the most frequent endocrine neoplasia. Different types of thyroid
carcinoma are described: well-differentiated papillary thyroid carcinoma (PTC), poorly …

Differentiated thyroid cancer (DTC) is the most common endocrinological malignancy. There
are several histological variants such as papillary and follicular thyroid carcinoma. Many …

Carcinomas of the thyroid comprise a heterogeneous group of neoplasms with distinctive
clinical and pathological characteristics. Over the past 15 years, the application of molecular …